Osirus AI has launched a new unified platform designed for the comprehensive building, deploying, and management of enterprise AI agents. This platform consolidates various AI capabilities such as Chat, Search, Image, Video, Speech, and Storage, integrated with major AI providers like AWS Bedrock, Google, and OpenAI. Alongside this, Osirus AI introduces the Agent Studio, a system enabling organizations to manage AI agents efficiently with substantial control and scalability across business operations. This development addresses common issues faced by organizations using multiple AI subscriptions without unified oversight, facilitating more seamless integration and management of AI technologies.

• Alphabet (NasdaqGS:GOOGL) last closed at $337.42 down 1.2%, close to the 52-week high.

Elsewhere in the market, Accton Technology (TWSE:2345) was a notable mover up 9.2% and finishing the session at NT$2,190.00, near its 52-week high. Meanwhile, Sharetronic Data Technology (SZSE:300857) trailed, down 29.4% to close at CN¥217.55.

Best Cloud AI Stocks

• Oracle (NYSE:ORCL) settled at $177.58 up 1.4%. On Monday, the company announced its integration with CLEAR1 for seamless patient identity verification and data access in healthcare settings.
• Apple (NasdaqGS:AAPL) closed at $273.05 up 1%. This week, Apple announced Tim Cook will become executive chairman and John Ternus the next CEO, effective September 1, 2026.
• Microsoft (NasdaqGS:MSFT) finished trading at $418.07 down 1.1%.

Make It Happen

• Unlock our comprehensive list of 141 Cloud AI Stocks like Delton Technology (Guangzhou), Scout24 and 360 Security Technology by clicking here.
• Ready For A Different Approach? AI is about to change healthcare. These 127 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Sources: